Healthcare
Deals across the sector
Although market activity has slowed from recent peak levels, we are seeing continued interest within the sector, particularly from investors for example private equity.
With interest rates remaining high, there is pressure on raising debt finance, and the ability for businesses to absorb higher interest rates. This is exacerbated by workforce costs remaining high and ongoing pressures in staffing, and the inflationary impact on other costs.
Consequently, there is a squeeze in margins as businesses struggle to pass on rising costs to their customers and public sector funding remains challenging.
Looking forward, we see significant opportunities for growth in the sector. In particular, the trend towards digitalisation and greater efficiencies through technology advancements. This needs to be balanced with the commercial needs of the business whilst ensuring quality of patient care delivery. ESG is likely to become more central to business strategy and investor requirements going forward.
This is going to require additional investment as it is still in its infancy within the sector for mid-market businesses.
Deals activity
The transactions market for healthcare has remained relatively strong in 2023 with high levels of deal appetite. With interest in the sector being underpinned by wider macro-economic and social factors, we expect this to continue into 2024.
Notable deals our team have been involved in include:
The sale Kenward Orthopaedic Limited, a leading orthotic footwear company, to private equity backed Ability Matters Group Limited.
The sale of Fingerprint Global Limited, a provider of specialised audit and lifecycle tracking solutions of surgical instruments, to Aliter Capital.
We provided transaction services to Acacium Group Limited on its acquisition of US based Sumo Medical Staffing Limited.